ERBB2 and invasive ductal breast carcinoma: In one case series published in 2013, specimens from 5 patients diagnosed with primary ductal adenocarcinoma of the lacrimal gland, an uncommon subtype, were tested for Her-2 overexpression; this was positive in 3 cases [5].